Patrick D’Haese is a full professor at Antwerp University where he has been heading up the Laboratory of Pathophysiology, the former Laboratory of Nephrology, for the past 15 years. Basically being a chemist, he obtained his Ph.D in Medical Sciences at the University of Amsterdam in the Netherlands in 1988. During his scientific career he has developed expertise in clinical, experimental and in vitro research dealing with bone disease (in particular renal osteodystrophy), calcified tissues (vascular calcification, nephrocalcinosis), renal toxicity, drug transport and heavy metal toxicity in renal failure. With regard to his interest in bone, he has been involved in the establishment of the KDIGO guidelines for the standardization of quantitative bone histomorphometry and diagnosis of renal osteodystrophy. He is also active as a member of Advisory Boards of pharmaceutical companies with particular interest on CKD and related mineral disorders. He has been the promoter of several doctoral theses and (co-) authored more than 250 papers in scientific journals, several of which have evaluated the safety of lanthanum carbonate (Fosrenol) as a human medicine. Lanthanum is the active P-binding ingredient in Phoslock. His H-index is 46 (WoS); 53 (Google Scholar)
Karin Finsterle is a Marine and Freshwater Ecologist based in Northern Italy. Originally from Germany, she undertook her post-graduate studies at the Carl von Ossietzky University in Oldenburg. Since moving to Italy 20 years ago, she has worked on water and environmental quality management projects and has been actively involved in bathing water quality assessment programs. Since 2010, she has been working as a limnological consultant on Phoslock related lake restoration projects in Europe and North America. She is a co-author of several scientific publications dealing with Phoslock as a management tool for lakes suffering from eutrophication and Phoslock related toxicity assessments.
Nigel Traill joined Phoslock Water Solutions (PWS) when the company was first established in 1999. He is currently based in the U.K. and is responsible for the Phoslock businesses in Europe, the Middle East and North and South America. He relocated to Europe from Australia in 2005 in order to establish PWS’ European Office, which provides scientific support services to PWS and PWS licensees globally. Prior to joining PWS, he was the Deputy Commissioner for the Queensland Government’s Trade and Investment Office in Tokyo, Japan. He holds a Masters Degree from the University of Queensland.